Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Bone Marrow Transplantation
|
November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
L Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation
|
May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
E Todisco, F Ciceri, C Boschini, et al.
Bone Marrow Transplantation
|
March 22, 2016
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
R Crocchiolo, L Castagna, S Furst, et al.
British Journal of Haematology
|
November 9, 2021
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT
G Gutiérrez-García, C Martínez, A Boumendil, et al.
Leukemia
|
March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients
A Rambaldi, A Bacigalupo, R Fanin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation
C Martínez, C Canals, B Sarina, et al.
Bone Marrow Transplantation
|
January 10, 2017
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
J Gauthier, L Castagna, F Garnier, et al.
British Journal of Cancer
|
October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
U Thiel, E Koscielniak, F Blaeschke, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Bone Marrow Transplantation
|
November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
L Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation
|
May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
E Todisco, F Ciceri, C Boschini, et al.
Bone Marrow Transplantation
|
March 22, 2016
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
R Crocchiolo, L Castagna, S Furst, et al.
British Journal of Haematology
|
November 9, 2021
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT
G Gutiérrez-García, C Martínez, A Boumendil, et al.
Leukemia
|
March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients
A Rambaldi, A Bacigalupo, R Fanin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation
C Martínez, C Canals, B Sarina, et al.
Bone Marrow Transplantation
|
January 10, 2017
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
J Gauthier, L Castagna, F Garnier, et al.
British Journal of Cancer
|
October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
U Thiel, E Koscielniak, F Blaeschke, et al.
Page
of 10